NOD2 and colitis: In addition, we found that MDP administration ameliorated the severity of colitis in WT mice, but not in either group of Blau-KI mice (Figures 6E–H).These data are consistent with the BS-NOD2 over-expression studies described above in suggesting that BS-NOD2 lacks a normal capacity to regulate mucosal inflammation.